Samar Almehdi: First-line chemotherapy in Iraqi patients with extensive-stage SCLC
Samar Almehdi, Medical Oncology Specialist at Iraqi Cancer Council, shared a post on LinkedIn about a recent paper she co-authored with Azher Al Zubaidi published in the Iraqi Postgraduate Medical Journal:
“Thrilled to announce that my and professor Dr. Azher Sebieh’s latest paper, titled ‘Patients Profile, Pattern of Presentation, and Response Rate to First-Line Chemotherapy in Iraqi Patients with Extensive-Stage Small Cell Lung Cancer,’ has been published in the Iraqi Postgraduate Journal!
Grateful to my co-author, mentors, and collaborators for their invaluable support throughout this journey.
I hope this research adds value to the field and sparks further discussions. Looking forward to engaging with peers on this topic!”
Authors: Samar Almehdi and Azher Al Zubaidi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023